Profile details
Profil Connor Smith
Connor is an Associate in our New York office focusing on public and private M&A and corporate matters.
Mandate
- CVC on its pending $925 million global carve-out acquisition of Therakos from Mallinckrodt
- SERB Pharmaceuticals, a portfolio company of Charterhouse Capital Partners, on its acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit from Emergent BioSolutions.
- AstraZeneca on its $1.1bn acquisition of Icosavax.
- Roivant Sciences on its $7.1bn pending sale of Telavant to Roche.
- Aristocrat Leisure on its $1.2bn acquisition of Nasdaq-listed Neogames.
Qualifikationen
Education
- Boston College Law School, JD, magna cum laude, May 2022
- Northwestern University, BA, cum laude, June 2016
Bar Admission
New York